Robert Hofmeister
Director/Board Member chez ALAUNOS THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Robert Hofmeister is an Independent Director at Alaunos Therapeutics, Inc. and a Co-Managing Director at Molkerei Hainichen Freiberg GmbH & Co. KG.
He was previously the Global Head-Translational Immunotherapy at EMD Serono Research & Development Institute, Inc. from 2012 to 2015 and the Senior Vice President-Research & Development at TCR2 Therapeutics, Inc. from 2015 to 2022.
He holds a doctorate degree from the University of Regensburg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Robert Hofmeister
| Sociétés | Poste | Début |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 30/03/2023 |
Molkerei Hainichen Freiberg GmbH & Co. KG
 Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Part of Ehrmann AG, Molkerei Hainichen Freiberg GmbH & Co. KG is a dairy company based in Freiberg, Germany. The CEOs are Christian Ehrmann, Sabine Arazi, Robert Hofmeister. The German company manufactures and produces high-quality dairy products with a focus on sustainability. The private company has a code of conduct and offer various career opportunities. The company was founded in 1992. | Chief Executive Officer | - |
Anciens postes connus de Robert Hofmeister
| Sociétés | Poste | Fin |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/03/2022 |
| EMD Serono Research & Development Institute, Inc. | Corporate Officer/Principal | 01/01/2015 |
Formation de Robert Hofmeister
| University of Regensburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| EMD Serono Research & Development Institute, Inc. | |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Molkerei Hainichen Freiberg GmbH & Co. KG
Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Part of Ehrmann AG, Molkerei Hainichen Freiberg GmbH & Co. KG is a dairy company based in Freiberg, Germany. The CEOs are Christian Ehrmann, Sabine Arazi, Robert Hofmeister. The German company manufactures and produces high-quality dairy products with a focus on sustainability. The private company has a code of conduct and offer various career opportunities. The company was founded in 1992. | Consumer Non-Durables |
